Financial Issues | News

Insurance Company Squabbles Cause Stress for Patients

April 19th 2018

By Bonnie Annis

Being unsure of medical coverage can cause cancer patients undue stress, which is very unhealthy.

Cancer in a Country With Socialized Medicine

March 26th 2018

By Shira Zwebner

When you're fighting for your life, you shouldn't have to worry about going into debt because of cancer-related costs

Love Over Fear

March 22nd 2018

By Kristie L. Kahl

In this episode, we’ll talk with founder Donna Deegan herself about the foundation and its efforts, as well as the foundation’s executive director Amanda Napolitano on how much they have raised so far, and we’ll hear from one very inspiring participant Hollis Youngner.

Changing Our Health Care Values

February 21st 2018

By Andrew Smith

Within a complex and expensive health system, there are ways to cut both individual and societal costs without harming the quality of care.

Tips for Managing the Cost of Cancer and Related Procedures

February 19th 2018

By Tamera Anderson-Hanna

There is no doubt that cancer can be costly, but there are some things you can do to help lessen the financial impact of the disease.

Efficacy Offsets High Costs for Immunotherapy in US, But Not Overseas

February 14th 2018

By Brielle Benyon

Researchers from Israel, the United Kingdom (UK) and Canada sought to determine the cost-effectiveness of Keytruda for the second-line treatment of patients with advanced bladder cancer. Drug costs were compared between the US, UK, Canada and Australia.

Returning to Work After Cancer Treatment

January 30th 2018

By Victoria Puzo, LCSW

For many cancer survivors, returning to work can be both exciting and anxiety-inducing. Knowing your rights and making a plan can help ensure a smooth transition.

Patients Concerned as Humana Takes Herceptin Off Preferred Drug List in South Florida

January 30th 2018

By Brielle Benyon

Until recently, Herceptin, which is used to treat patients with metastatic breast cancer, was fully covered under Humana’s South Florida Medicare Advantage plans. But, after taking it off the preferred drug list, patients will now be responsible for 20 percent of the drug’s cost, better aligning South Florida’s plans with Humana’s other Medicare Advantage plans.

Money: The Dark Side of Cancer

January 29th 2018

By Kim Johnson

No matter how expensive treatment was, we didn’t want to put a price tag on my sister’s life.

When the Patient Is the Loser

January 19th 2018

By Martha Carlson

A major insurer takes a 20-year, first-line standard treatment off its preferred list in one market. But where will it end?